舍圖控股(08392.HK)認購短期基金若干股份
格隆匯 12 月 28日丨舍圖控股(08392.HK)公吿,舍圖控股有限公司董事會謹此宣佈認購事項,據此,公司全資附屬公司逸豐於2020年4月1日及2020年12月28日分別以金額33萬美元及100萬美元認購短期基金若干參與股份。短期基金乃由中銀香港資產管理有限公司管理。
鑑於近期集團銀行存款利率低息,董事考慮可最大程度上提高本集團盈餘現金儲備回報多種方法。經審慎考慮後,董事認為,投資短期基金可提高資金效益及效率。經考慮投資風險相較於認購事項潛在回報妥為考慮到公司經濟需要後,董事會認為,認購事項條款乃按正常商業條款訂立,屬公平合理,並符合本公司及其股東整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.